In silico exploration of acetic acid driven multicomponent synthesis: design, characterization, and antioxidant evaluation of spiroacridines and spiroquinolines

In this study, a highly efficient green synthetic protocol was developed for the synthesis of spiroacridines and spiroquinolines via a multicomponent reaction of 3,4-methylenedioxyaniline, isatin and cyclic 1,3-diones in glacial acetic acid. This metal-free multicomponent approach offers mild reacti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RSC sustainability 2024-04, Vol.2 (4), p.1128-1141
Hauptverfasser: Patel, Subham G., Upadhyay, Dipti B., Shah, Nirajkumar V., Parmar, Mehul P., Patel, Paras J., Malik, Apoorva, Sharma, Rakesh K., Patel, Hitendra M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study, a highly efficient green synthetic protocol was developed for the synthesis of spiroacridines and spiroquinolines via a multicomponent reaction of 3,4-methylenedioxyaniline, isatin and cyclic 1,3-diones in glacial acetic acid. This metal-free multicomponent approach offers mild reaction conditions, shorter reaction time and easy product purification without column chromatography. Frontier molecular orbitals (FMOs), various quantum chemical descriptors (QCDs) and molecular electrostatic potential (MEP) surfaces were computed using density functional theory (DFT) with a B3LYP/6-311G+(d,p) basis set. All newly synthesized compounds were screened for their antioxidant properties. The compounds 4a and 4v are the most potent ABTS and DPPH radical scavengers to the standard ascorbic acid. In silico molecular docking studies were conducted to determine the binding affinities of the most potent 4a and 4v with targeted antioxidant protein, ld -carboxypeptidase, which show a strong binding affinity of −10.5 kcal mol −1 and −10.7 kcal mol −1 , respectively. The most potent antioxidants 4a and 4v were evaluated for in silico drug-likeness and ADME prediction.
ISSN:2753-8125
2753-8125
DOI:10.1039/D4SU00024B